Skip to main content
Fig. 1 | BMC Gastroenterology

Fig. 1

From: Capecitabine plus bevacizumab versus capecitabine in maintenance treatment for untreated characterised KRAS exon 2 wild-type metastatic colorectal cancer: a retrospective analysis in Chinese postmenopausal women

Fig. 1

Flow diagram demonstrating methods for identification of studies to retrospectively evaluate the efficacy and safety of CAP-B versus CAP in maintenance treatment after 6-cycle CAPOXB induction therapy in Chinese postmenopausal women with untreated characterised KRAS exon 2 wild-type MCC

Back to article page

BMC Gastroenterology

ISSN: 1471-230X

Contact us